Answers are grounded in this paper and cite their sources.
Demonstrates reduction of kidney lesions in CLL-associated glomerulopathy after ibrutinib therapy, indicating its potential benefit.
A 61-year-old man was referred for nephrotic syndrome with a urine protein-to-creatinine ratio of 5.97 g/gCr, serum albumin of 2.6 g/dL, and serum creatinine of 0.71 mg/dL (Figure 1A, Supplementary Table S1). Initial monoclonal studies were non-diagnostic. Kidney biopsy showed mild mesangial matrix expansion (Figure 1C) and glomerular basement membrane thickening with focal spikes and bubbling (Figure 1D). Immunofluorescence demonstrated segmental IgG1-κ restriction (Figure 1G, I), and electron microscopy revealed organized fibrillary-to-microtubular deposits measuring approximately 22 nm, with focal parallel alignment (Figure 1E, F).
No takes yet. Share an insight, caveat, or question.
Shibuki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: